Ddfg, Inc Gilead Sciences, Inc. Transaction History

Ddfg, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$73.27 - $83.09 $3,004 - $3,406	41 Added 0.96%	4,319 $349,000
Q3 2023 Nov 02, 2023	BUY	$73.94 - $80.67 $3,105 - $3,388	42 Added 0.99%	4,278 $321 Million
Q2 2023 Aug 09, 2023	BUY	$76.01 - $86.7 $3,116 - $3,554	41 Added 0.98%	4,236 $327 Million
Q1 2023 May 05, 2023	BUY	$77.31 - $88.08 $3,015 - $3,435	39 Added 0.94%	4,195 $348 Million
Q4 2022 Mar 01, 2023	BUY	$62.32 - $89.47 $259,001 - $371,837	4,156 New	4,156 $357 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Ddfg, Inc, based on Form 13F filings with the SEC.

Stay updated on Ddfg, Inc with notifications on news.